Microorganisms hindering cancer therapy have more influence than the beneficial ones, study says

Melanoma patients receiving therapy that helps their immune system kill cancer cells respond to treatment differently depending on the types of microbes in their gut, and new research suggests the microorganisms hindering therapy have more influence than the beneficial ones.

Related Keywords

United States ,American ,Amiran Dzutsev ,Hassane Zarour ,Giorgio Trinchieri ,Natalia Shulzhenko ,Emily Henderson ,National Cancer Institute ,National Institutes Of Health ,University Of Pittsburgh ,Frederick National Laboratory For Cancer Research ,Oregon State Carlson College Of Veterinary Medicine ,College Of Pharmacy ,American Cancer Society ,Oregon State University ,Frederick National Laboratory ,Cancer Research ,Andrey Morgun ,American Cancer ,Oregon State ,Carlson College ,Veterinary Medicine ,National Institutes ,National Cancer ,Bacteria ,Dancer ,Immunotherapy ,Ancer Immunotherapy ,Immune System ,Laboratory ,Medicine ,Melanoma ,Icrobiome ,Pharmacy ,Research ,Skin ,Skin Cancer ,